Loading company…
Copenhagen microfluidics company whose Xdrop platform enables single-cell functional assays and genomic analysis.
Founded in 2013 in Copenhagen, Denmark, Samplix ApS develops microfluidics technology, with its Xdrop platform used for single-cell functional assays and genomic analyses. The system uses double-emulsion droplet technology to encapsulate biomolecules and serves researchers in cell biology, immunotherapy and genomics across North America, Europe and Asia. Fjord Capital Partners acquired the company in January 2013, and Lars Kongsbak is the CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in